-
Featured
What We Have Learned About COVID-19: Part One
Since the initial outbreak of COVID-19, clinicians have treated hundreds of thousands of patients. At the same time, over 55,000 COVID-related research articles have been published (albeit of heterogeneous quality). There is now substantial consensus on optimal treatment of the critically ill patient with COVID-19.
-
Do Adenovirus Vaccines Cause Clotting?
Many people are asking...do adenovirus vaccines cause clotting?
-
The Burden of Cognitive Dysfunction in COVID-19
Many people are asking…what is the burden of cognitive dysfunction in COVID-19?
-
Update in Sedation and Analgesia Management in COVID-19 ARDS
In this FLARE, the team and clinicians from Vanderbilt University Medical Center provide a brief review of the state of knowledge regarding best practices for sedation and analgesia in patients receiving mechanical ventilation and an update on literature to date specific to COVID-19.
-
Are The Two Newly Authorized COVID-19 Vaccines Safe and Effective?
The FDA issued an EUA for two vaccine candidates from Pfizer-BioNTech and Moderna. Both vaccines report an efficacy of around 95% across different age groups, sex, ethnicity, and comorbidity risk status, which is extremely encouraging as COVID-19 cases in the US continue to climb.
-
COVID-19 Vaccine Candidates
The effort to produce and distribute a SARS-CoV-2 vaccine has made remarkable progress. Currently there are over 180 candidate vaccines against SARS-CoV-2 in development worldwide.
FLARE Contributors
-
Camille Petri, MD
Research Fellow, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Helmet Ventilation May Be Considered for Selected Patients with Mild COVID-19–Associated ARDS -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
COVID-19 ARDS Has Distinct Phenotypes Different from Those in "Classic" ARDS
-
David M. Dudzinski, MD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Erica Seiguer Shenoy, MD, PhD
Associate Physician, Massachusetts General Hospital, Associate Chief of the Infection Control Unit, Massachusetts General Hospital
Recent Article
Diagnostic Algorithm Supports Evaluation of Hospitalized COVID-19 Patients After Initial Negative Test
-
Jason H. Maley, MD
Research Fellow in Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19 -
Laura N. Brenner, MD
Pulmonologist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Cats and Bats and Pangolins: The Origin of Sars-Cov-2 -
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Tiara Calhoun, MD
Internal Medicine and Global Medicine Resident, Massachusetts General Hospital
Recent Article
Study of Interferon + Antivirals in COVID-19 Is First Published Randomized Trial with Positive Results -
Vladimir Vinarsky, MD
Instructor in Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Neutralizing SARS-CoV-2-specific Antibodies and Virus-Specific T Cells Detected in People Recovering from COVID-19
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.Related Links
